In sharp contrast, the HR (HR = 1.85 (1.19–2.88)) was greater in TNBC, indicating that a high TSP1 mRNA expression level in tumor samples can be considered as an independent bad prognosis biomarker in TNBC, but not in all breast cancers. This evidence concerns the gene THBS1 and neoplasm.